Robert Gray
Chief Executive Officer chez NANOSTRING TECHNOLOGIES, INC.
Fortune : 39 300 $ au 31/03/2024
Profil
Robert Bradley Gray is currently the President, Chief Executive Officer & Director at NanoString Technologies, Inc. He previously worked as the Vice President-Product & Business Development at Genzyme Genetics, Inc. from 2008 to 2010 and as the Director-Corporate Development at Genzyme Corp.
He has an undergraduate degree from the University of Oxford and another undergraduate degree from the Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/03/2024 | 491 247 ( 1,02% ) | 39 300 $ | 31/03/2024 |
Postes actifs de Robert Gray
| Sociétés | Poste | Début |
|---|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Chief Executive Officer | 29/06/2010 |
Anciens postes connus de Robert Gray
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Genetics, Inc.
 Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Corporate Officer/Principal | 01/05/2010 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Robert Gray
| University of Oxford | Undergraduate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Health Services |
